Viewing Study NCT00096304


Ignite Creation Date: 2025-12-24 @ 7:49 PM
Ignite Modification Date: 2026-03-02 @ 4:09 AM
Study NCT ID: NCT00096304
Status: TERMINATED
Last Update Posted: 2018-04-10
First Post: 2004-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Sponsor: Medical University of South Carolina
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module